Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat critically ill patients with serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers.

Print   Email Title Type Size   2010 Annual Report /10-K 2.2 MB 2009 Annual Report /10-K 1.3 MB 2008 Annual Report /10-K 715.5 KB 2007 Annual Report 537.4 KB 2006 Annual Report /10-K 733.8 KB 2005 Annual Report /10-K 1.1 MB 2004 Annual Report /10-K 98.1 KB 2003 Annual Report /10-K 107.6 KB 2002 Annual Report /10-K 92.5 KB 2001 Annual Report /10-K 92.8 KB 2000 Annual Report /10-K 80.0 KB 1999 Annual Report /10-K 105.4 KB 1998 Annual Report /10-K 103.3 KB 1997 Annual Report /10-K 123.1 KB = add file to Briefcase